Caitong International Asset Management’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
OAG
PA
BBA
VCM
DM
DCM
CAM
Caitong International Asset Management's PRAX Position: Q1 2026 in Review
Caitong International Asset Management opened a new position in Praxis Precision Medicines (PRAX) in Q1 2026: 472 shares worth $152K. The stake represents 0.03% of the portfolio and ranks #455 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in PRAX as recently as Q2 2025.
Caitong International Asset Management first reported a position in PRAX in Q2 2025 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.
- Caitong International Asset Management held 472 shares of Praxis Precision Medicines worth $152K as of Q1 2026.
- Praxis Precision Medicines was a new Caitong International Asset Management position in Q1 2026.
- Praxis Precision Medicines made up 0.03% of Caitong International Asset Management's portfolio in Q1 2026, its #455 holding.
- Caitong International Asset Management first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 2 quarters since.
- 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.
Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.